Safety of Onartuzumab in Patients with Solid Tumors: Experience to Date from the Onartuzumab Clinical Trial Program

類似資料

• A Phase II Randomized Trial (GO27827) of First‐Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer
  著者:: Bendell, Johanna C., 等
  出版事項: (2017)
• Profile of nintedanib in the treatment of solid tumors: the evidence to date
  著者:: Awasthi, Niranjan, 等
  出版事項: (2015)
• Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma: The METGastric Randomized Clinical Trial
  著者:: Shah, Manish A., 等
  出版事項: (2016)
• Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
  著者:: Spigel, David R., 等
  出版事項: (2013)
• Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature
  著者:: Mirrakhimov, Aibek E., 等
  出版事項: (2014)